Improved method for measurement of human plasma xanthine oxidoreductase activity.
The XOR activity in human plasma was measured by quantifying the XOR-derived uric acid (UA) in plasma using the high-performance liquid chromatography (HPLC) equipped with a UV detector. Chromatographic separation consisted of the mobile phase (a mixture of 0.1% trifluoroacetic acid in Milli-Q water and 0.085% trifluoroacetic acid in acetonitrile in a mix ratio of 99:1) running through a Zorbax StableBond SB-C(18) column at a flow-rate of 1 ml/min. Deproteinization with heat-treatment of plasma samples after the reaction was used in the assay to avoid splitting of the UA and xanthine peaks caused by acid deproteinization that could interfere the accurate determination of human plasma XOR activity in our case. Based on the examination of the dependence of XOR activity on added amounts of xanthine and reaction times, the amount of xanthine and reaction time for XOR activity assay were determined to prevent the errors caused by the limiting effect of substrates and plateau phase of the reaction. Using this method, human plasma XOR activities of 25 healthy people were measured. The average human plasma XOR activity was 2.1+/-0.8 (x10(-3) U/ml).
Liu
X
X
Laboratory of Genomic Physiology, School of Life Sciences, Fudan University, Shanghai 200433, PR China.
Lin
W M
WM
Yan
X H
XH
Chen
X H
XH
Hoidal
J R
JR
Xu
P
P
D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D006801:Humans; D012016:Reference Values; D012680:Sensitivity and Specificity; D013056:Spectrophotometry, Ultraviolet; D014969:Xanthine Oxidase / Q000097:blood*
D014969:Xanthine Oxidase